+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes

Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes

Molecular Cancer Therapeutics 12(5): 643-653

The ruthenium (II) polypyridyl complexes (RPC), Δ-[(phen)2Ru(tatpp)]Cl2 (Δ-[3]Cl2) and ΔΔ-[(phen)2Ru(tatpp)Ru(phen)2]Cl4 (ΔΔ-[4]Cl4, are a new generation of metal-based antitumor agents. These RPCs bind DNA via intercalation of the tatpp ligand, which itself is redox-active and is easily reduced at biologically relevant potentials. We have previously shown that RPC 4(4+) cleaves DNA when reduced by glutathione to a radical species and that this DNA cleavage is potentiated under hypoxic conditions in vitro. Here, we show that 3(2+) also exhibits free radical-mediated DNA cleavage in vitro and that 3(2+) and 4(4+) both exhibit selective cytotoxicity toward cultured malignant cell lines and marked inhibition of tumor growth in vivo. The murine acute toxicity of RPCs 3(2+) and 4(4+) (maximum tolerable doses ~ 65 μmol/kg) is comparable with that for cisplatin (LD50 ~ 57 μmol/kg), but unlike cisplatin, RPCs are generally cleared from the body unchanged via renal excretion without appreciable metabolism or nephrotoxic side effects. RPCs 3(2+) and 4(4+) are shown to suppress growth of human non-small cell lung carcinoma (~83%), show potentiated cytotoxicity in vitro under hypoxic conditions, and induce apoptosis through both intrinsic and extrinsic pathways. The novel hypoxia-enhanced DNA cleavage activity and biologic activity suggest a promising new anticancer pharmacophore based on metal complexes with aromatic ligands that are easily reduced at biologically accessible potentials.

(PDF emailed within 0-6 h: $19.90)

Accession: 055446935

Download citation: RISBibTeXText

PMID: 23443803

DOI: 10.1158/1535-7163.MCT-12-1130

Related references

Hypoxia-Sensitizing Ruthenium Polypyridyl Complexes. 2013

Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?. Journal of Inorganic Biochemistry 150: 174-181, 2016

Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells. Inorganic Chemistry 49(14): 6366-6368, 2010

Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models. Chemistry 21(2): 715-725, 2015

A new strategy for the improvement of photophysical properties in ruthenium(II) polypyridyl complexes. Synthesis and photophysical and electrochemical characterization of six mononuclear ruthenium(II) bisterpyridine-type complexes. Inorganic Chemistry 44(9): 3215-3225, 2005

Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells. Journal of Biological Inorganic Chemistry 19(3): 335-348, 2014

Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase. Metallomics 6(8): 1480-1490, 2015

Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis. Chemistry, An Asian Journal 11(2): 310-320, 2016

Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets. European Journal of Medicinal Chemistry 82: 82-95, 2015

Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling. Dalton Transactions 43(45): 17017-17028, 2015

Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N--N)]Cl2 with N--N=bpy, phen, dpq, dppz, and dppn. Chemmedchem 3(7): 1104-1109, 2008

Electrocatalytic reduction of CO2 to CO by polypyridyl ruthenium complexes. Chemical Communications 47(47): 12607-9, 2011

Ruthenium(II) polypyridyl complexes as carriers for DNA delivery. Chemical Communications 47(39): 11068-11070, 2012

Self-assembled supramolecular cages containing ruthenium(II) polypyridyl complexes. Chemical Communications 51(21): 4465-4468, 2015

Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. Biochemistry. 34(38): 12369-12378, 1995